Blog | HemaCare

PBMC Estrogen Receptor α Gene Expression May Predict Response to Interferon Therapy in Patients with Chronic Hepatitis B Infection

Jan 16, 2017 12:00:23 AM / by Stacy Matthews Branch, DVM, PhD posted in bioresearch, PBMCs, pegylated interferon, Infectious Disease, Basic Research


Hepatitis B is a viral infection that can cause liver damage. Most healthy adults that contract the acute infection can be symptom free and clear the virus. Some people cannot clear the virus after several months, developing the chronic form of the infection. Pegylated interferon is a slow-release form of an immune molecule that has been shown to inhibit virus replication and limit liver damage.

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts